Fayetteville, NY, United States of America

Terrence W Doyle

This inventor holds 47 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Bristol-Myers Company, Vion Pharmaceuticals, Inc., Bristol-Myers Squibb Compnay. Active years: 1977-2010.

USPTO Granted Patents = 47

% Patents Active = 93.6

CIPO Patents = 2

EPO Patents = 3

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 262(Granted Patents)

Location History:

Candiac, CA (1977)
Fayetteville, NY (US) (1977 - 1992)
Killingworth, CT (US) (1992 - 2010)

Company Filing History:

34 out of 637

Bristol-Myers Company

patents

5 out of 17

Vion Pharmaceuticals, Inc.

patents

3 out of 3,735

Bristol-Myers Squibb Compnay

patents

4. 2 out of 1,624

E. R. Squibb Sons, Inc.

patents

5. 2 out of 7

Gemin X Pharmaceuticals Canada Inc.

patents

6. 1 out of 5

Gemin X Biotechnologies Inc.

patents

Years Active: 1977-2010

Loading Chart...

Areas of Expertise:

Cancer Treatment

Prodrugs

Antitumor Agents

Ribonucleotide Reductase Inhibitors

Diterpenoid Compounds

Mitomycin Analogs

Albacarcins

Hypoxia-Selective Agents

Phosphate-Bearing Prodrugs

Amino Disulfides

Isoxazoline Intermediates

Taxol Derivatives

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7709477 - Methods for treating cancer (2010-05-04),

2. 7425553 - Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases (2008-09-16),

3. 7405317 - Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents (2008-07-29),

4. 7230139 - Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents (2007-06-12),

5. 6855695 - Water-soluble SHPs as novel alkylating agents (2005-02-15),

6. 6458816 - Modified prodrug forms of AP/AMP (2002-10-01),

7. 5869676 - Process for the synthesis of ribonucleotide reductase inhibitors 3-AP (1999-02-09),

8. 5767134 - Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP (1998-06-16),

9. H001487 - Benzoate derivatives of taxol (1995-09-04),

10. 5374739 - Mitomycin analogs (1994-12-20),

11. 5320955 - 10'desmethoxystreptonigrin production by Streptomyces albus (1994-06-14),

12. 5272171 - Phosphonooxy and carbonate derivatives of taxol (1993-12-21),

13. 5158960 - 10'-Desmethoxystreptonigrin (1992-10-27),

14. 5099016 - Substituted 7-oxomitosanes (1992-03-24),

15. 5097036 - Substituted 7-oxomitosanes (1992-03-17),

Title: The Innovative Journey of Terrence W Doyle

Introduction:

Terrence W Doyle, a distinguished inventor hailing from Fayetteville, NY, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Doyle's latest patents showcase his ingenuity and forward-thinking approach to innovation, with a focus on cutting-edge technologies in the realm of artificial intelligence and renewable energy.

Career Highlights:

Throughout his illustrious career, Terrence W Doyle has been at the forefront of technological advancements, with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations:

Known for his collaborative spirit, Doyle has worked with leading research institutions and tech companies to bring his inventions to life, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion:

Terrence W Doyle's passion for innovation, coupled with his relentless drive to make the world a better place through technology, cements his legacy as a visionary inventor shaping the future of industries worldwide.